Insights on Clinical Trials

  1. How AI & Biomarkers Are Reshaping The Next Frontier In Drug Development 9/18/2025

    Learn more about the importance of biomarker-driven drug development and the integration of laboratory science, clinical expertise, and regulatory strategy to accelerate targeted therapy development.

  2. Phase 1 Clinical Trial Designs And Strategies 9/18/2025

    With tailored guidance, sponsors can align their modern model-based and model-assisted design choices to program goals, accelerating progress while safeguarding patients.

  3. The Evolving Landscape Of Oncology Drug Development 9/17/2025

    Explore the novel drug modalities poised to revolutionize oncology and improve patient outcomes.

  4. How To Ensure EHR Data Integrity Without Compromising 9/15/2025

    Learn how EHR-to-EDC integration can streamline clinical trials, boosting accuracy, efficiency, and compliance.

  5. How AI Is Reshaping The Future Of Clinical Research 9/15/2025

    Artificial intelligence (AI) is rapidly transforming clinical research, with innovative applications in key areas such as real-world evidence generation, regulatory submissions, and biomarker discovery.

  6. Is Digital Recruitment For Clinical Trials Ethical By Design? 9/15/2025

    Clinical trial recruitment is increasingly digital. Learn about the ethical considerations and how transparency and trust lead to better outcomes.

  7. The Data Dilemma: Balancing Innovation With Trust In Healthcare 9/15/2025

    Despite frequent data breaches, patients remain willing to share their health data with trusted healthcare providers that prioritize transparency and ethical stewardship.

  8. Revitalizing Recruitment In A Lupus Rescue Study 9/11/2025

    Recruitment hurdles are overcome by leveraging engaged, data-sharing patient communities. See how a strategic, patient-centric approach delivered a pre-qualified clinical trial cohort quickly and efficiently.

  9. Developing Community-Based & Trial-Naïve Sites: The Real ROI 9/9/2025

    Trial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment.

  10. GLP-1 Ocular Safety Monitoring At Point-Of-Need 9/8/2025

    Regulators are sharpening their focus on ocular safety in GLP-1 receptor agonist trials following emerging evidence linking semaglutide to non-arteritic anterior ischemic optic neuropathy (NAION).